ZEISS continues to drive digital era forward in ophthalmology

2 million digitally planned cataract cases in the U.S. alone.

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Heidi Stensmyren is eager for new challenges in the biotech industry

management roles,” she says.

Gelhype, börsras och fetmastudie – här är nyheterna som lästes mest i oktober

En ny studie pekar ut varför många patienter avbryter behandling med den nya sortens läkemedel mot obesitas. Det är den nyhet som har lästs mest den här månaden.

Ingrid Lönnstedt: What does the p-value mean?

The smaller the better, and preferably smaller than 0.05. A p-value smaller than 5% means that the treatment effect is statistically significant at 5% significa...

Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma

Webinar | March 13, 2024, 12 PM EST.

Promising Alzheimer’s study data sends Bioarctic stock soaring

The drug candidate lecanemab from Swedish company Bioarctic significantly slowed down the deterioration in patients with early on-set Alzheimer’s, according to ...

Final assembly inspection of medical plastics

Technical paper by ZEISS Medical Industry Solutions.

AstraZeneca to use American AI platform for cancer trials

In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.

The Swedish innovation model: “There is a paradox”

It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?

Klartecken för Eli Lillys alzheimerläkemedel i EU – blir konkurrent till Leqembi

EU-kommissionen gör tummen upp för alzheimerläkemedlet Kisunla från Eli Lilly, som därmed blir den andra godkända bromsbehandlingen för sjukdomen i EU.

Innovative start-up helps doctors, scientists and industry balance coagulation risks

For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”

It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...

A green nursery for biotech rooted in the Scanian soil

Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...

“What is important is to create an overview and understanding from different perspectives”

Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...

WuXi AppTec, UK Ltd

Startskott för Leqembi i EU – lansering inleds i Österrike

Idag, måndag, inleds lanseringen i EU av svenskutvecklade Alzheimerläkemedlet Leqembi. Först ut är Österrike, följt av Tyskland.

AI speeds up measurement process

How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.

“A major energy boost for the entire cancer vaccine field”

The development of cancer vaccines has accelerated in recent years. Norwegian Ultimovacs is one of the companies attempting to develop a new type of treatment l...

Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis

Free webinar organized by ZEISS.

Rising interest in CRISPR treatments

Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.

Sanofi backar efter besvikelse i KOL-studie

Blandade resultat för KOL-behandlingen Itepekimab i två fas III-studier fick Sanofis och Regenerons aktier att backa ordentligt på fredagen.

Efficient use of blood plasma

Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...